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ABSTRACT
Zika virus is an enveloped virus with a single-stranded positive-sense RNA genome. The
Zika virus is a member of the Flaviviridae family of viruses that was discovered to infect humans
in 1952. The Flavivirus envelope is decorated by many copies of two membrane proteins that
facilitate viral entry. The virus is primarily transmitted through mosquito bites. Another method
by which Zika virus could be transmitted is through sexual contact with Zika infected partners or
from an infected pregnant woman to fetus known as congenital transmission. Infected patients
suffer from self-limiting febrile illness including headaches, skin rash myalgia, and
conjunctivitis. Zika virus has a significant impact on pregnancies, causing developmental defects
in fetal brain that leads to infants born with smaller head size, a disorder known as microcephaly.
Zika virus has also been linked to the increase of the development of neurological disorder
known as Guillain-Barre syndrome. Zika virus has been involved in multiple outbreaks around
the world, beginning in 2007 where the Zika virus infected about 5,000 of the people of Yap
Island in Micronesia. The following outbreak began between 2013-2014, affecting about 30,000
people in French Polynesia. In 2015-2016, Zika virus outbreak was reported to affect the
Americas, where over 30,000 cases and about 4300 microcephaly cases. Upon entry into host
cells, Zika virus begins to unpack and release the RNA genome to express the viral proteins as
well as to replicate the RNA genome. Studies have revealed that autophagy, which is a cellular
mechanism that protects host cells during starvation and pathogenic infections, is associated with
Zika replication as it may facilitate the replication of the Zika virus. Here, we investigated the
effects of autophagy in the replication of Zika virus using an autophagy inducer, rapamycin. For
this study, we used a human trophoblast cell line which is physiologically relevant to congenital
transmission of Zika virus. To better understand how autophagy is involved in Zika replication in
x

trophoblast cells, a knockout was generated on one of the autophagy gene known as ATG12. The
ATG12 autophagy protein forms a complex with another autophagy protein known as ATG5.
PCR analysis revealed that the relative Zika viral load was increased in cells treated with
rapamycin when compared to non-rapamycin treated cells. Consistent with the rapamycin
treatment results, Zika replication was lower in ATG12-/- than wild type cells. Interestingly, the
effect of rapamycin on Zika replication was abolished in ATG12-/- cells. These findings suggest
that autophagy facilitates Zika replication. Understanding the effects that autophagy imposes on
the replication of the Zika virus could provide therapeutic opportunities through designing drugs
that control the autophagy by either entirely blocking the autophagy mechanism or partially in
patients who have been infected with Zika virus. Another avenue that would benefit from
controlling autophagy is by strategizing delivery of autophagy blockers to pregnant patients to
control the severity of developmental disorders in fetuses such as microcephaly.

xi

INTRODUCTION
1. Background
Zika virus (ZIKV) is a member of the Flaviviridae family of viruses that was
discovered in 1947 (Agrelli, de Moura, Crovella, & Brandão, 2019; Weaver et al., 2016).
The ZIKV was known to be a threat to public health globally due to the virus being vectorborne transmitted through mosquito bites (X. Zhang et al., 2017). Additionally, ZIKV
transmission can also occur through sexual contact with partners infected with ZIKV
(D’Ortenzio et al., 2016). Infected patients suffer from self-limiting febrile illness including
headaches, skin rash myalgia, and conjunctivitis (Liu, Shi, & Qin, 2019). ZIKV has a
significant impact on pregnancies, causing developmental defects in the head that leads to
infants born with a smaller brain, a disorder known as microcephaly (Vianna et al., 2018; Yu
et al., 2017). ZIKV has also been linked to a neurological disorder in adults known as
Guillain-Barre syndrome (GBS), a neuromuscular disorder that results from the
immunopathogenesis against the peripheral nervous system (Agrelli et al., 2019; Yuki &
Hartung, 2012). ZIKV has been involved in multiple outbreaks around the world, beginning
in 2007 where the virus infected about 5,000 of the people of Yap Island in Micronesia. The
following outbreak began between 2013-2014, affecting about 30,000 people in French
Polynesia (Agrelli et al., 2019). In 2015-2016, ZIKV outbreak was reported in the Americas,
where up to 33 countries and territories were affected with around 30,000 ZIKV infection
cases and over 4300 reported microcephaly cases. (Faria et al., 2016; Petersen, Jamieson,
Powers, & Honein, 2016).

Figure 1: Comparison between typical head size and moderate microcephaly and severe microcephaly.
Originally published in (Petersen et al., 2016)

2. Transmission
2.1 Transmission by mosquitoes
ZIKV is an arthropod-borne virus that relies on a mosquito vector to spread (D Musso
et al., 2014). The transmission of ZIKV is carried mainly by Aedes aegypti mosquitos (Ioos
et al., 2014). Mosquito transmission of ZIKV virus begins when a mosquito bites an
individual infected with ZIKV for a blood meal (Abushouk, Negida, & Ahmed, 2016; Didier
Musso & Gubler, 2016). The mosquito contracts the ZIKV from the infected individual and
becomes a carrier of the ZIKV. The ZIKV-infected mosquito bites another individual that is
not infected with ZIKV for a blood meal. The ZIKV-infected mosquito will transmit the
ZIKV to the individual, infecting the individual with ZIKV. The transmission cycle continues
when another mosquito that does not carry the ZIKV bites the ZIKV-infected individual
(Abushouk et al., 2016).

2

2.2 Sexual Transmission
The transmission of the ZIKV is not only limited to mosquitos; other modes of
transmission can also deliver the virus to healthy individuals. One of the modes of
transmission of ZIKV is through sexual contact (Abushouk et al., 2016; Quicke et al., 2016).
Sexual contact with partners infected with ZIKV has been proved to pass ZIKV to a naive
individual. The ability of ZIKV to be transmitted sexually is due to the presence of the viral
particles in the vaginal and seminal fluids (Abushouk et al., 2016; Didier Musso & Gubler,
2016).
2.3 Vertical Transmission
Another mode of transmission is through the passing of the ZIKV from infected
mothers to their babies. The type of transmission that relies on the mother-to-baby
transmission is known as vertical transmission or maternal-fetal transmission (Abushouk et
al., 2016; Liu et al., 2019). The reason for the ZIKV to be transmitted to the fetus of the
ZIKV -positive mother is that the virus can penetrate the placental barrier and replicate in the
fetus (Quicke et al., 2016). The presence of the ZIKV particles in the amniotic fluids and in
the fetus of the mothers infected with ZIKV is evidence of vertical transmission (Quicke et
al., 2016; Silverstein, Aljouda, & Kumar, 2016).

3

Figure 2: Routes of entry for Zika virus. Originally published in (Liu et al., 2019)

3. Genome
ZIKV is a single-stranded RNA virus. The RNA molecule of ZIKV is in a positivesense conformation (Abushouk et al., 2016; X. Zhang et al., 2017). The positive-sense
conformation of RNA molecules in viruses can be processed as a messenger RNA, which is
subject for translational machinery (Paranjape & Harris, 2010). The process of hijacking the
host translational machinery allows the ZIKV to express the genes that code for structural
proteins as well as nonstructural proteins. The structural proteins that are encoded in the
ZIKV genome are C, PrM, and E proteins. These proteins are responsible for making up the
4

viral particles of the ZIKV. The C protein in ZIKV forms the capsid that houses the genomic
material of the ZIKV (Shan et al., 2016). The proteins that are encoded by the E gene form
the glycoprotein envelope that surrounds the ZIKV capsid (Liu et al., 2019; Shan et al., 2016;
X. Zhang et al., 2017). The PrM gene codes for a protein that works in concert with the E
protein. Together, the PrM and the E protein form PrM-E heterodimers. The PrM-E
heterodimers play a major role in the development of immature ZIKV visions (Zhu et al.,
2016). Whereas the non-structural proteins that ZIKV codes for are NS1, NS2A, NS2B, NS3,
NS4A, 2K, NS4B, and NS5 (Liu et al., 2019; Shafique, 2017). The non-structural proteins
are required for the replication process of the ZIKV genome inside the host cells (Shan et al.,
2016).

Figure 3: Zika virus structure and genome. Originally published in (Asif et al., 2017)
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3.1 Structural proteins
3.1.1

Capsid
There are three structural proteins encoded by the ZIKV genome. From the 5’ end of

the genome, the C gene, which is the first gene of the structural genes, codes for the capsid
protein (Fontaine et al., 2018; Liu et al., 2019; Shang, Song, Shi, Qi, & Gao, 2018). The
capsid is a protein that surrounds the viral genome. One of the roles the capsid protein plays
is to provide a level of protection to the viral genome from environmental factors
(Nuanualsuwan & Cliver, 2003). The capsid is also responsible for the delivery of the virus
into hosts cells and releasing genetic material in the cytoplasm (Bothner, Dong, Bibbs,
Johnson, & Siuzdak, 1998; Nuanualsuwan & Cliver, 2003). The structure of viruses is
broadly classified based on the 3-dimensional morphology of the capsid (Baron, 1996). The
Flaviviridae family of viruses assumes an icosahedral structure (Agrelli et al., 2019; Plevka
et al., 2011). The capsid protein forms a nucleocapsid when the RNA molecule of the ZIKV
enters host cells. The nucleocapsid formation occurs as the virus is being assembled for
budding out of the infected cell to infect neighboring cells (Shang et al., 2018). It has also
been discovered that the capsid of the ZIKV localizes into the nucleus of host cells during the
replication of the virus (Fontaine et al., 2018).
Additionally, the capsid protein of dengue virus, which is another member of the
Flaviviridae family that is closely related to ZIKV, disrupts the assembly process of
nucleosomes by binding to the histone protein in the nucleus. Blocking the nucleosome
assembly of the infected host cells interferes with the host gene expression (Colpitts, Barthel,
Wang, & Fikrig, 2011). It has also been discovered that the capsid protein of the ZIKV and
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other members of the Flaviviridae can positively regulate the production of viral particles
(Rawlinson & Moseley, 2015; Slomnicki et al., 2017).
3.1.2

Envelope
The third protein to be encoded by the ZIKV genome is the envelope protein, which

surrounds the capsid of the ZIKV. The envelope is composed of glycoprotein protein formed
as a result of expressing the envelope protein (E). The E protein is crucial for the viral
infection of host cells. The structure of the E protein allows the virus to bind to host cellular
receptors and to facilitate fusion with the host’s membrane to release the virus inside the host
cells (X. Zhang et al., 2017). To enable the virus to survive inside a human host, the
structural properties of the E proteins can aid the virus in avoiding antibody neutralization
(X. Zhang et al., 2017).
The E protein consists of four domains each serving multiple functions (X. Zhang et
al., 2017). Three domains of the E protein are EDI, EDII, and EDIII (X. Zhang et al., 2017).
The fourth domain of the E protein is at the base of the structure known as the stemtransmembrane domain that serves as an anchorage for the E protein domains (Shafique,
2017). The EDI domain is positioned between the EDII and EDIII domains and serves as a
scaffold protein that is necessary for maintaining the structural orientations of the overall E
protein. The EDI domain aids in the viral attachment to the cells and can facilitate
neurovirulence through the position of conserved residues at Asn154, an N-linked
glycosylation site. The E protein is also susceptible to conformational changes occurring by
the EDI domain due to the nature of the pH environment to facilitate the fusion to host cells.
These residues at the EDI domain pose an additional set of properties that favor the
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production of the ZIKV particles, as well as an increase in neuroinvasiveness of the virus (X.
Zhang et al., 2017).
EDII domain is positioned towards the peripheral part of the E protein, above the EDI
domain (X. Zhang et al., 2017). This domain, with the aid of the EDI domain, facilitates the
fusion with the membrane of host cells (Shafique, 2017; X. Zhang et al., 2017). The
membrane fusion process is carried out through the 98–110 amino acid sequence, which is a
highly conserved sequence that forms what is known as the fusion loop (X. Zhang et al.,
2017). The fusion loops interact with the membrane of host cells, and the viral membrane as
the E protein undergoes conformational changes with pH change (Gratton, Agrelli, Tricarico,
Brandão, & Crovella, 2019; Shafique, 2017; X. Zhang et al., 2017). The consequence of
fusion between the membrane of the ZIKV and the membrane of host cells is that host cells
engulf the virus in an endosome. The inside of the endosome will have a very acidic
environment that induces conformational changes to the ZIKV envelope, facilitating the
fusion (Agrelli et al., 2019).
The third domain of the E protein is the EDIII, which is positioned towards the inner
side of the E protein and is connected to the stem domain (Shafique, 2017). Sulfide-sulfide
bridges contribute to the stability of the connection to the stem domain (X. Zhang et al.,
2017). The EDIII domain provides sites complementary to cellular receptors to facilitates
binding. The structure of the EDIII domain is known to play a role in triggering antibodies to
neutralize the E protein of the ZIKV. This domain is subject to being used for designing
monoclonal antibodies to target the ZIKV and other members of the Flaviviridae (Shafique,
2017)
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Figure 4: Structural domains of envelope protein. (X. Zhang et al., 2017)

3.2 Non-structural protein
After the viral genome is being released in the cytoplasm of the infected host cell and
translated into a polyprotein, the host proteases begin cleaving the polyprotein with the help
of viral proteases into 10 structural and non-structural proteins (Abushouk et al., 2016; X.
Zhang et al., 2017). The non-structural (NS) proteins play a crucial role in viral replication as
well as the participation in virulence and immune evasion. The NS1 protein is one of the
seven non-structural proteins. The main function of the intracellular NS1 protein is to
9

facilitate the replication process of RNA of the ZIKV (Nogales et al., 2017; Sager, Gabaglio,
Sztul, & Belov, 2018; Zou et al., 2015). When the NS1 is localized into the lumen of the ER
it undergoes processing, allowing the NS1 to be associated with the membrane (mNS1) (Asif
et al., 2017). When the NS1 proteins are either membrane-bound or secreted, the complement
system activation will be prevented and the Toll-like receptors become activated (Zhu et al.,
2016).
The NS3, along with the NS2B acting as a cofactor, is responsible for cleavage the
polyprotein of the ZIKV (Li, Phoo, & Luo, 2014; Zou et al., 2015). The NS3 also participates
in the replication of the viral RNA by acting as a helicase (Li et al., 2014). The helicase
activity prevents the formation of dsRNA ahead of the replication complex (Jankowsky &
Fairman, 2007). Additionally, NS3 also carries a nucleotide phosphatase and RNA
triphosphatase activities (Li et al., 2014).
NS4A and NS4B are membrane-integrated proteins that mediated the replication
process of the Flaviviridae family of viruses (Zou et al., 2015). These two proteins are
cleaved by the NS3 protein in complex with the NS2A proteins by their protease activity (Li
et al., 2014). The replication complex formation is facilitated by the NS4A protein when it
interacts with the vimentin (Zou et al., 2015). Additionally, both NS4A and NS4B proteins
are also responsible for interfering with the antiviral response in infected cells. Both NS4A
and NS4B proteins interfere with the JAK/STAT pathway. According to Ma et al, the
interactions of RLR-MAVS are being blocked by the NS4A, suggesting that the NS4A has a
suppressive activity towards the RLR pathway. In stem cells, both NS4A and NS4B proteins
interfere with the signaling of AKT-mTOR. As a result, cellular autophagy mechanism is
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induced. Links between the interference of AKT-mTOR and microcephaly development have
been reported (Ma et al., 2018).
The NS5 protein is also responsible for the replication of the RNA of ZIKV. The NS5
protein carries an enzymatic activity that is known as RNA-dependent RNA polymerase
(RdRp) (Lin, Chang, Yu, Liao, & Lin, 2006). The RdRp is a type of polymerase that is
specialized in replicating RNA molecules (Li et al., 2014; Zou et al., 2015). The NS5 is also
responsible for the RNA modifications by acting as a methyltransferase and
guanyltransferase (Grant et al., 2016; Li et al., 2014; Lin et al., 2006). The capping of the
RNA also allows the RNA to be recognized for translation by the eukaryotic initiation factor
4 E (eIF4E). The recognition of the viral cap by the eIF4E triggers the host translational
machinery of the viral RNA (Coutard et al., 2017). NS5 proteins also have negative effects
on the immunological pathways. The presence of the NS5 proteins in infected cells inhibit
the signaling for the JAK-STAT pathways that are induced by type I IFN (Ashour et al.,
2010; Best et al., 2005; Grant et al., 2016; Lin et al., 2006).
4. Replication Cycle:
Upon the entry of a host cell, ZIKV begins its replication cycle to produce mature
virion that leaves the infected cells to infect other cells, repeating the cycle (Heinz & Stiasny,
2017). The replication cycle consists of several events that are crucial for the success of the
replication cycle. The first step of the replication cycle is the receptor recognition and
attachment of the host cells by the ZIKV. One of the major components of the envelope in
the ZIKV is the E protein, which consists of multiple domains known as EDI, EDII, and
EDIII. The EDIII facilitates the entry of ZIKV by interacting with surface receptors of the
host cells (Heinz & Stiasny, 2017; X. Zhang et al., 2017). These cell surface receptors are
11

heparan sulfates, carbohydrate receptors, ribosomal protein SA, and low-density lipoprotein
receptor-related protein 1 (LRP1) (X. Zhang et al., 2017). The interaction with the cell
surface receptors induces the cells to uptake the ZIKV through endocytosis, keeping the virus
in an endosomal vacuole. This process is known as receptor-induced endocytosis (Heinz &
Stiasny, 2017; X. Zhang et al., 2017).
Following the ZIKV entry through the induced endocytosis, the virus begins the
process of membrane fusion (Cann, 2001; Heinz & Stiasny, 2017; Savidis et al., 2016; X.
Zhang et al., 2017). The membrane fusion allows the envelope of the ZIKV to fuse with the
endosomal membrane, leading to the uncoating of nucleocapsid and the release of the viral
genome into the host cytoplasm (Agrelli et al., 2019; Cann, 2001; Savidis et al., 2016; X.
Zhang et al., 2017). The membrane fusion is triggered by the acidic environment inside the
endosomal vacuole. This acidic environment induces a conformational change of the E
protein (Cann, 2001; Savidis et al., 2016; X. Zhang et al., 2017). The fusion process is
facilitated by the EDII domain of the E protein, which contains a region known as the fusion
loop (X. Zhang et al., 2017).
Once the RNA molecule of ZIKV is released in the cytoplasm, the RNA molecule
begins the translation process (Agrelli et al., 2019). The translation process of ZIKV
produces the essential structural and non-structural proteins that are essential for the viral
assembly (Agrelli et al., 2019; X. Zhang et al., 2017). The translational event also produces
an enzyme crucial to the replication process of ZIKV. This enzyme is RdRp. The RdRp
utilizes the viral RNA to synthesize new RNA molecules (Cann, 2001; Saiz et al., 2016). The
RdRp activity is carried out by one of the non-structural proteins NS5 (Lin et al., 2006; Zhao
et al., 2017). The replication process occurs in the endoplasmic reticulum, where the newly
12

synthesized viral RNA undergoes modifications that prevent their degradation from the
cytoplasmic environment, as well as allows as the RNA molecules to be recognizable by the
eIF4E for translational events (Coutard et al., 2017; Grant et al., 2016; Li et al., 2014; Lin et
al., 2006).
Once both translational and replicative events are completed, the assembly of ZIKV
begins (Atif, Azeem, Sarwar, & Bashir, 2016; Saiz et al., 2016). The assembly process of
ZIKV where the newly RNA molecule assembles with the capsid, PrM, and envelope
proteins (Heinz & Stiasny, 2017; Saiz et al., 2016; Sikka et al., 2016). The product of the
assembly is an immature virion. These virions channel through the Golgi apparatus where
they use the trans-Golgi network (TGN) to utilize the exocytotic pathway (Atif et al., 2016;
Heinz & Stiasny, 2017; Saiz et al., 2016). The virions then complete their maturation by
cleaving the PrM by furin enzyme (Heinz & Stiasny, 2017; Saiz et al., 2016). Once the Zika
virions are packaged and have become fully maturated, they are released by the process of
exocytosis and begin infecting neighboring cells (Atif et al., 2016; Heinz & Stiasny, 2017).
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Figure 5: Zika virus replication cycle. Originally published in (Heinz & Stiasny, 2017)

5. Pathogenesis
ZIKV pathogenesis in humans causes a range of diseases from self-limiting illness to
severe disorders (Liu et al., 2019). ZIKV infections through mosquito bites allow entry via
the skin cells; fibroblast, keratinocytes and immature dendritic cell (Abushouk et al., 2016;
14

Didier Musso & Gubler, 2016; Plourde & Bloch, 2016). The entry of ZIKV is facilitated by
entry and adhesion factors that assist the viral infection and autophagy induction, which has
been associated with enhanced viral replication. ZIKV disseminates into other tissues such as
spleen, brain, spinal cord, kidney, eye and placenta in pregnant women. ZIKV dissemination
is facilitated using migration into the blood circulation through the lymphatic system
(Plourde & Bloch, 2016).
One of the mechanisms ZIKV that contribute to the pathogenesis is the induction of
apoptotic events in neural progenitor cells. This mechanism may significantly impact brain
development and leading to microcephaly development (Miner, Diamond, & microbe, 2017).
GBS development can also occur as ZIKV targets the neural cells. Reports indicate that
neural illness begins six days before the development of the neurological symptoms,
suggesting the presence of ZIKV infection in neural cells (Cao-Lormeau et al., 2016).
6. Autophagy
As the ZIKV infects cells and undergoes the replicative cycle, cellular pathways that
induce autophagy formation are triggered (Saiz et al., 2016). Autophagy is a cellular
mechanism that is initiated due to cellular maintenance or in response to environmental
stresses (Glick, Barth, & Macleod, 2010; Gratton et al., 2019; Jung, Ro, Cao, Otto, & Kim,
2010; Rabinowitz & White, 2010). Autophagy mechanisms are classified into three different
types; macroautophagy, microautophagy, and chaperone-mediated autophagy (Gratton et al.,
2019; Jung et al., 2010; Mizushima & development, 2007; Rabinowitz & White, 2010).
Macroautophagy, which represents the term autophagy, is a mechanism that forms a doublemembrane vesicle know as an autophagosome (Gratton et al., 2019; Klionsky, Eskelinen, &
Deretic, 2014; Shoji-Kawata & Levine, 2009; Silvestrini et al., 2018). This vesicle is formed
15

around cellular waste components that are destined for degradation (cargo). The
autophagosomal vesicle undergoes membrane fusion with a lysosome, forming
autophagolysosome (APL) (Ballou & Lin, 2008; Gratton et al., 2019; Klionsky et al., 2014;
Silvestrini et al., 2018). The fusion with the lysosome causes degradation of the APL’s cargo
due to high acidity (Glick et al., 2010). Microautophagy is the process of direct lysosomal
uptake of the cargo where it gets degraded. The chaperone-mediated autophagy pathway
utilizes the chaperone HS70 and a lysosomal membrane protein 2A (LAMP2A) (Glick et al.,
2010; Mejlvang et al., 2018; Mizushima & development, 2007).
The process of autophagy is regulated by multiple factors. One of these factors is
mTOR (Ballou & Lin, 2008; Jung et al., 2010; Ma et al., 2018). mTOR is a member of the
PIKK, phosphatidylinositol kinase-related kinase (Jung et al., 2010). This kinase
phosphorylates serine/threonine residues (Ballou & Lin, 2008). Regulation of mTOR activity
affects the signaling pathways that induce autophagy. The activation of mTOR has a negative
regulatory effect on the autophagy formation. Activated mTOR inhibits the induction of the
autophagy. Environmental stress condition alters the activity states of mTOR, blocking their
functions (Ballou & Lin, 2008; Jung et al., 2010). One of these stressors is starvation. Under
starvation conditions, cells utilize autophagy to recycle nutrients and misfolded proteins to
produce precursors necessary for the generation of essential nutrients for survival (Ballou &
Lin, 2008; Shoji-Kawata & Levine, 2009).
The formation of the autophagosome requires the assembly of autophagy-related
genes (ATG) (Wesselborg & Stork, 2015). To date, about 31 ATG proteins have been
discovered that are associated with autophagosome formation (Glick et al., 2010; Mizushima
& development, 2007). These ATG proteins work in concert throughout the process of
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autophagy. For example, ATG17, ATG29, ATG31, and ATG11 proteins are responsible for
the formation of pre-autophagosome structures (PAS) (Glick et al., 2010; Jung et al., 2010;
Mizushima & development, 2007). Other ATG proteins, such as ATG8, are responsible for
the membrane fusion with the lysosome (Jung et al., 2010; Mejlvang et al., 2018; Mizushima
& development, 2007). Some of the ATG proteins form complexes with other ATG proteins
in order for them to become functional. An example of ATG complexes is the ATG12-ATG5
complex,

which

functions

in

facilitating

the

conjugation

of

ATG8

with

phosphatidylethanolamine (PE) (Jung et al., 2010). The ATG12-ATG5 conjugate forms a
complex with ATG16 that aids in the formation of the phagophore, in addition to recruiting
LC3B-II (Glick et al., 2010).
Interestingly, autophagy pathways can also be induced in response to intracellular
pathogens (Rabinowitz & White, 2010; Shoji-Kawata & Levine, 2009). Viral infections
stress the cell and cause the inhibition of mTOR pathways induces autophagy in the infected
cells. Viral infections cause the formation of virus-containing autophagic vesicles in an
attempt to degrade the virus. The antiviral mechanism of autophagy can limit viral
replications of some viruses, including Sindbis virus, resulting in reduced viral titers in the
CNS (Gratton et al., 2019).
The placental immune system utilizes autophagy formation as one of the defensive
mechanisms used against pathogenic stresses. One of the pathogenic stressors that induce
autophagy formation is ZIKV. The induction of autophagy in placental cells infected with
ZIKV could be triggered due to the expression of the non-structural genes NS4A and NS4B
(Chiramel & Best, 2018; Ma et al., 2018; S. Miller, Kastner, Krijnse-Locker, Buhler, &
Bartenschlager, 2007; Sven Miller, Sparacio, & Bartenschlager, 2006; Paul &
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Bartenschlager, 2015). Reports have indicated that NS4A and NS4B proteins promote
autophagy formation using the inhibitory Akt-mTOR pathway (Chiramel & Best, 2018).
Autophagy formation in cells infected with ZIKV seems to act as a pro-viral mechanism
(Yuan, Zhang, Li, & microbiology, 2017). Recent studies have suggested that autophagy
formation may facilitate ZIKV replication and transmission (Cao, Parnell, Diamond, &
Mysorekar, 2017). The autophagic vacuole is thought to provide a protective barrier from the
immune system (Zhang, Li, Yuan, & microbiology, 2017). ZIKV also is also involved in
blocking the lysosomal fusion with the autophagosome to prevent its degradation and to
provide a safer environment for replication (Yuan et al., 2017).

Figure 6: Autophagy formation steps. Originally published in (Mizushima & development, 2007)
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SPECIFIC AIMS AND HYPOTHESIS
In our study, we wanted to evaluate the effect of autophagy on the replication of
ZIKV in human trophoblasts, which are physiologically relevant to ZIKV vertical
transmission and fetal infection. To investigate whether the replication of ZIKV is hindered
by autophagy deficiency, we created an autophagy gene knockout known as ATG12 in a
human trophoblast cell line. Then, we wanted to see if induction of autophagy by rapamycin,
an mTOR inhibitor and an autophagy inducer would result in higher viral loads. We
hypothesized that the use of rapamycin would enhance ZIKV replication.
Aim: Determining whether the autophagy formation in trophoblast would facilitate the
replication of ZIKV
We generated ATG12 gene knockout in trophoblast cells to determine whether
autophagy deficiency would hinder the replication of ZIKV. We have also treated cells with
rapamycin to determine if autophagy induction would increase the viral replication of ZIKV
in trophoblast cells.
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MATERIALS AND METHODS
1. Cell culture and virus
The primary cell line that was used for this study is human placental trophoblast. For
this experiment, the trophoblast cells were cultured at 37C in a 5% CO2 incubator. The cells
were cultured in RPMI medium with 10% of FBS and 1% pen-strep antibiotic. Trophoblast
ATG12 gene knockout (ATG12-/-) was generated and was kindly provided by my lab
colleague. The ATG12-/- trophoblast cells were cultured in RPMI medium with 10% FBS and
1% pen-strep antibiotic. The trophoblast cells were incubated at 37ºC in a 5% CO2 incubator.
Vero cell line was also used in the study for ZIKV propagation. The cells were
cultured in DMEM medium with 10% FBS and 1% pen-strep antibiotic. Vero cells were
incubated at 37ºC in the CO2 incubator.
ZIKV was kindly supplied by one of my lab colleagues. The virus was propagated in
Vero cells for 72hrs. The ZIKV was stored at -80ºC.
2. Reagents and antibodies
The antibodies used for the western blot analysis were mouse anti-ATG12 (Cat#
MAB6807) that was purchased from R&D systems; rabbit anti-LC3B (Cat# 2775), and Actin
(Cat# 8456) were purchased from Cell Signaling Technology (Danvers, MA, United States).
Rapamycin (Cat# 553210) was purchased from EMD Millipore Corp (Billerica, MA, United
States). PrimeScript™ RT Reagent Kit (Perfect Real Time) (Cat# RR07A) was purchased
from Takara Bio Inc (Mountain View, CA, United States).
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3. Western blotting
The Western blot technique was used to confirm that the ATG12 knockout of the
trophoblast had been generated. The wild type (WT) and the ATG12-/- were incubated until
the cells were about 90% confluent. The cells were extracted by removing the old medium
and treating the cells for 1 minute with cold PBS, which then was removed. The cells were
then dislodged by pipetting fresh medium. Once the cells were suspended in fresh medium,
the cells were pelleted by centrifugation at 1000 rpm. After removal of the supernatant, the
isolated cells were lysed with cold lysis buffer and placed on ice. The constituents of the lysis
buffer included 0.5% NP-40, 50 nM Tris-HCL, pH 7.4, 2 mM EDTA, protease inhibitors and
150 mM NaCl. The cells were then subjected to centrifugation at 10,000 rpm, and the
supernatant was collected for western blot analysis. The supernatant was treated with loading
buffer and subjected to SDS gel electrophoresis. The protein bands generated on the SDS gel
were transferred to the membrane. The membrane was blocked with 5% milk for 1 hour, then
probed with anti-ATG12 and anti-LC3 primary antibodies that were purchased from Cell
Signaling. The membranes were incubated with the primary antibodies overnight at 4°C. The
antibodies were diluted in 5% milk and the concentration were following manufactures
specifications. Anti-actin antibodies were used as a control for this experiment. Then, the
membrane was incubated with secondary antibodies for 1hr at 4ºC. The membrane was then
treated with a chemiluminescent substrate and was exposed to a film. The film was then
developed using a film developer.
4. ZIKV infection and rapamycin treatment
The WT and ATG12-/- trophoblast cells were cultured to about 90% confluence. The
medium was removed, cells were washed with cold PBS for 1 minute, and dislodged by
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applying fresh RPMI medium. WT and ATG12-/- cells were each was seeded in a 24-well
plate and incubated until reaching confluence. The medium was then removed, and the cells
were treated with ZIKV in all wells for 3 hours. The medium containing the virus was then
removed and replaced with a fresh RPMI medium. Half of the wells in the 24-well plate were
treated with 100 nM rapamycin, while the other half were treated with 50 nM rapamycin for
3 hours. The medium was replaced with fresh medium thatalso contained rapamycin. The
cells in the 24-well plate were incubated at 37°C in a CO2 incubator for 24hrs or 48hrs . At
these time points, the WT and the ATG12-/- cell samples were lysed using TRK lysis buffer.
5. RNA extraction and qPCR analysis
Total RNA was extracted from the lysed WT or the ATG12-/- trophoblast cells using
the E.Z.N.A. Total RNA Kit I by OMEGA. The isolated RNA samples were subjected to RTPCR using the PrimeScript™ RT Reagent Kit (Perfect Real Time) to generate cDNA. The
cDNA samples were then subjected to qPCR analysis. The targets for the cDNA samples
consisted

of

ZIKV,

IFNB1,

and

Actin.

The

ZIKV

primers

used

were

CCGCTGCCCAACACAAG-3’ and 5’CCACTAACGTTCTTTTGCAGACAT-3’.

5’
The

IFNB1 primer (Hs01077958_s1) used in the qPCR analysis was purchased from
ThermoFisher Scientific. The viral load was calculated using the -ΔΔCT method and was
compared to the values of the beta-actin genes.
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RESULTS
1. Confirmation of ATG12 Gene Knockout in Trophoblast Cells
The trophoblast gene knockout of ATG12 was generated previously by a lab
colleague. To determine whether the gene has been deleted successfully, Western blot
analysis was performed on WT and ATG12-/-. At about 55 kDa, we observed a band in the
WT lane. The anti-ATG12 antibody was detected at in WT cells. The anti-ATG12 antibody
was not detected at the same molecular weight, 55 kDa in ATG12-/- cells. This suggests
observation suggests that the ATG12 protein was absent in ATG12-/- cells, confirming a
successful gene knockout of the ATG12.
To further confirm that the ATG12 gene was successfully knocked out, another
autophagy-related protein that is associated with the ATG12-ATG5 conjugates was
investigated. This protein is LC3B-II. Anti-LC3 antibody was used to detect the presence of
LC3B-I and LC3B-II proteins. The Anti-LC3B antibody detected the presence of LC3B-I at
16 kDa in the WT cells. At 14 kDa molecular weight, the anti-LC3B antibody did not
detected the presense of LC3B-II in the ATG12-/- cells. The absence of LC3B-II protein is an
indication of defects in ATG12-ATG5 conjugate as they are required for the lipidation of the
LC3B-II. These observations further confirmed that ATG12 gene was successfully knocked
out in trophoblast cells. (Fig. 7)
2. ZIKV Infection of ATG12 Deficient Trophoblast Cells
To investigate the effects of autophagy formation on the replication of ZIKV, we
transfected both WT and ATG12-/- trophoblast cells with ZIKV. The total RNA was
extracted from both WT and ATG12-/- trophoblast cells at three time points; 24, 48, and
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72hrs. RT-PCR was performed to synthesize cDNA. The cDNA samples were then subjected
to qPCR analysis. We have used primers targeting ZIKV, and IFNB1 to investigate the viral
load in response to autophagy deficiency, and to correlate the antiviral response to ZIKV
load. The qPCR analysis revealed that there is a significant decrease in the relative viral load
in response to autophagy deficiency at both 24 and 48hrs post-ZIKV infection when
compared to the WT with a P < 0.01. Past 48hrs, the relative viral load began to decline
gradually. These findings suggest that autophagy-deficiency hindered the ability of ZIKV to
replicate efficiently (Fig. 8).
The relative IFNB1 levels were significantly lower in ATG12-/- cells in the first 48hrs
post the ZIKV infection with P < 0.05. At 72hrs post-infection, the IFNB1 levels began to
decline gradually. The IFNB1 patterns are correlated with the relative viral load of ZIKV,
likely as a secondary result of reduced viral replication (Fig. 9).
3. ZIKV Infection of Trophoblast Cells Treated with Rapamycin
Now that we have confirmed that autophagy deficiency in trophoblast cells
significantly reduced the relative viral load, we wanted to determine whether autophagy
induction by rapamycin in trophoblast cells would increase the relative viral load in
trophoblast cells. Rapamycin is an mTOR inhibitor that induces autophagy formation. To
investigate the of rapamycin on ZIKV viral load, we treated both WT and ATG12-/- with two
different concentrations of rapamycin; 50 nM or 100 nM. The total RNA was extracted for
PCR analysis at 24 and 48hrs. The qPCR analysis revealed that rapamycin treatment in
trophoblast cells that at 24hrs post-infection, there was an increase in the relative viral load of
ZIKV in WT cells treated with 100 nM rapamycin. The relative viral load of ZIKV in WT
trophoblast cells treated with 50 nM rapamycin did not increase as much compared to WT
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cells treated with 100 nM rapamycin. Interestingly, both 50 nM and 100 nM rapamycin
treatment did not increase the viral load in ATG12-/- trophoblast cells (Fig. 10). However, at
48hrs, similar ZIKV loads were observed in both WT and ATG12-/- trophoblast cells that had
been treated with either 50 nM or 100 nM rapamycin. These findings suggest that 100 nM of
rapamycin treatment was sufficient enough to induce autophagy formation in WT trophoblast
cells, thus increasing the viral load of ZIKV. The low relative viral load in 50 nM rapamycintreated WT trophoblast cells may be an indication of an insufficient concentration of
rapamycin to induce enough autophagy formation. The findings at 48hrs indicate that the
ZIKV replication does not rely solely on the process of autophagy (Fig. 11).
We also trophoblast cells investigated the IFNB1 levels in ZIKV infections in
response to rapamycin treatment. At 24hrs post infection, IFNB1 levels were elevated in WT
at both 50 nM and 100 nM rapamycin concentrations when compared to the ATG12-/trophoblast cells (Fig. 12). At 48hrs, WT cells treated with 100 nM rapamycin displayed an
increase in IFNB1 levels. These findings were consistent with the IFNB1 patterns in Figure 9,
suggesting that the IFNB1 levels are correlated to the relative viral load of ZIKV (Fig. 13).
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Figure 7: ATG12 gene was successfully deleted in trophoblast cells. Cellular proteins of trophoblast were
separated on SDS-PAGE. Membranes were probed for the presence of ATG12, LC3BI/II, and Actin proteins.
The first lane represents WT trophoblast cell lysate. The second lane contains ATG12-/- trophoblast cell lysate.
Anti-ATG12 did not detect a product in ATG12-/- at 55 kDa, which would correspond to the ATG12-ATG5
conjugate. Similarly, anti-LC3B antibody did not detect LC3B-II in ATG12-/- cells. In summary, this Western
blot analysis confirms the successful gene deletion of ATG12 in trophoblast cells.
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Figure 8: ZIKV viral load was decreased in ATG12-/- cells. The relative viral load in WT trophoblast cells is
significantly higher in WT than in ATG12-/- trophoblast cells during the first 48hrs. The viral load then begins
to drop after 48hrs of the ZIKV infection. The plots indicate the mean of three replicates and error bars indicate
the standard deviation. P < 0.01, two-tailed student T test. This experiment was repeated twice.
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Figure 9: IFNB1 levels decreased in ATG12-/- cells in response to ZIKV. The relative levels of the IFNB1 in
response to the viral infection is at basal levels 24hs post infection. The IFNB1 levels begin to rise significantly
48 and 72hrs post infection. The plots indicate the mean of three replicates and error bars indicate the standard
deviation. P < 0.05, two-tailed student T test. This experiment was repeated twice.
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Figure 10: ZIKV viral load increased in WT trophoblast cells in response to 100 nM rapamycin 24hrs
post infection. Both WT and ATG12-/- were treated with either 50 nM or 100 nM of rapamycin drug. WT cells
treated with 100 nM of rapamycin display elevated levels of relative ZIKV viral load when compared to the
ATG12-/- at 24hrs post infection. There is a trend towards significance in the readings that was not achieved
due to the small sample size. Columns indicate the mean of three replicates and error bars indicate the standard
deviation. This experiment was conducted once.
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Figure 11: Similar ZIKV viral load in both cells treated with 50 nM or 100 nM rapamycin 48hrs post
infection. At 48hrs, the relative viral load of ZIKV in WT and ATG12-/- treated with either 50 nM or 100 nM
of Rapamycin begins to reach equilibrium. There is a trend towards significance in the readings that was not
achieved due to the small sample size. Columns indicate the mean of three replicates and error bars indicate the
standard deviation. This experiment was conducted once.
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Figure 12: IFNB1 levels increased in cells infected with ZIKV in response to 50 nM and 100 nM
rapamycin 24hrs post infection. Both WT and ATG12-/- were treated with wither 50 nM or 100 nM of
Rapamycin drug. At both dosages of Rapamycin, IFNB1 levels in WT were higher than ATG12-/- at 24hrs post
infection.. There is a trend towards significance in the readings that was not achieved due to the small sample
size. Columns indicate the mean of three replicates and error bars indicate the standard deviation. This
experiment was conducted once.
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Figure 13: Further increase in IFNB1 levels in cells infected with ZIKV in response to 100 nM rapamycin
48hrs post infection. At 48hrs, the IFNB1 levels in WT cells treated with 100 nM rapamycin increased by onefold. There is a trend towards significance in the readings that was not achieved due to the small sample size.
Columns indicate the mean of three replicates and error bars indicate the standard deviation. This experiment
was conducted once.
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DISCUSSION
Our primary goal in this study was to investigate the role of autophagy formation in
trophoblast cells in the replication of the ZIKV. We have created a scenario for the ZIKV
replication where the target cells were incapable of establishing autophagy. Then we
investigated how autophagy formation would impact the viral replication of ZIKV.
The fetus is protected from pathogenic infections through the placental barrier. When
a pathogen invades the placental barrier and infect placental cells, an immune response
becomes triggered, and other protective mechanisms such as autophagy are activated. During
pathogenic infections, autophagy formation captures the pathogen and fuses with the
lysosomal compartment to degrade the pathogen. In our study, we have confirmed that
autophagy formation provides a favorable environment for ZIKV to replicate. Generation of
a gene knockout of ATG12, which is crucial for the formation of the autophagophore, has
demonstrated the significance of autophagy in enhancing ZIKV replication in trophoblast
cells. Our observations confirm previous studies conducted with a different autophagyrelated gene, AT16L1. Additionally, our findings further strengthen the current
understanding regarding autophagy mechanism and ZIKV replication.
Autophagy is a crucial mechanism of cell survival. ZIKV infections take advantage of
the autophagosome formation. ZIKV has been known to induce autophagy once the NS4A
and NS4B are translated. NS4A and NS4B play a role in inducing autophagy in cells (Ma et
al., 2018). Our experiments have expanded our knowledge and understanding regarding
autophagy induction. We induced autophagy using a drug known as rapamycin. Rapamycin
is an mTOR inhibitor and an autophagy inducer. Autophagy induced with rapamycin resulted
in higher ZIKV viral load in WT trophoblast cells. Our results have confirmed that
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autophagy formation facilitates the viral replication of ZIKV. The effect of rapamycin on
ZIKV replication was abolished in ATG12 deficient trophoblast cells, which was expected
due to the absence of autophagophore formation. Rapamycin may induce autophagy, but the
cells were not able to form a robust autophagophore structure that surrounds the ZIKV.
Therefore, ZIKV was not able to replicate efficiently.
Due to the significant impact of ZIKV on placental and neural cells, therapeutic
interception is required to limit viral replication of ZIKV in the fetus and neuronal cells. Our
study demonstrates an alternative approach to limiting the viral replication of ZIKV in
trophoblast cells through autophagy regulation. Currently, multiple studies have
demonstrated promising results using drugs to limit the ZIKV replication in placental
trophoblast cells (Bayer et al., 2016; Delvecchio et al., 2016; Elfiky, 2016; Sacramento et al.,
2017; Xu et al., 2016; Zmurko et al., 2016). Combining these drugs with autophagy
inhibitors might provide a stronger suppression to the viral replication of ZIKV and may
limit the possibility of maternal-placental transmission. More studies are required to
investigate the combinational therapies using these promising anti-ZIKV drugs with
autophagy blockade drugs that target essential autophagy-related genes at both in vitro and in
vivo settings.
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